Itron (ITRI)
(Delayed Data from NSDQ)
$109.05 USD
+0.43 (0.40%)
Updated May 17, 2024 04:00 PM ET
After-Market: $109.11 +0.06 (0.06%) 7:58 PM ET
1-Strong Buy of 5 1
D Value B Growth D Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
ITRI 109.05 +0.43(0.40%)
Will ITRI be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for ITRI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ITRI
The Zacks Rank Explained: How to Find Strong Buy Computer and Technology Stocks
The Zacks Rank Explained: How to Find Strong Buy Computer and Technology Stocks
ITRI: What are Zacks experts saying now?
Zacks Private Portfolio Services
New Strong Buy Stocks for May 14th
Are You Looking for a Top Momentum Pick? Why Itron (ITRI) is a Great Choice
Here's How Much You'd Have If You Invested $1000 in Itron a Decade Ago
Other News for ITRI
Itron Announces Participation at Upcoming Investor Conferences
Aristotle Capital Small/Mid Cap Equity Q1 2024 Commentary
Aristotle Capital Small Cap Equity Q1 2024 Commentary
December 2025 Options Now Available For Itron (ITRI)
Itron Reaches Analyst Target Price